Skip to content

Da-vinci sp Versus xi Thyroid Surgery

One-year Clinical Experiences of Single-port and Multi-port Robotic Thyroid Surgery in Single Institution

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06573268
Enrollment
270
Registered
2024-08-27
Start date
2022-12-01
Completion date
2024-08-01
Last updated
2024-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer, Thyroid Nodule

Keywords

thyroid, robotic surgical procedures, minimally invasive surgical procedures

Brief summary

One year comparative analysis between SPRA\* versus BABA\*\* thyroid surgery. \* SPRA: da-Vinci SP Robotic Areolar approach thyroid surgery \*\* BABA: da-Vinci Xi robotic Bilateral. Axillary Breast Approach thyroid surgery

Detailed description

Study design: retrospective data analysis Study period: December 2022 to December 2023 Candidate: Patients who received robot thyroid surgery during study period Numbers of candidates: total of 270 patients Group : SPRA (n=111) versus BABA (n=159) Statistic analysis: t-test for continuous variable, fisher's exact test for categorical variable

Interventions

DEVICErobot surgery device

SPRA used da-Vinci SP system (SPRA) BABA used da-Vinci Xi system (BABA)

Sponsors

Inha University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who received robot thyroid surgery in our institution * Retrospective review

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frameDescription
Total operation time (minutes)on the surgery day (1 day)Time for spending total surgery

Secondary

MeasureTime frameDescription
Hospital stay days after surgeryafter the surgery day (up to 2 weeks)Hospital admission days after surgery

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026